# Study of Testosterone and rHGH in FSHD

> **NCT03123913** · PHASE1 · COMPLETED · sponsor: **University of Rochester** · enrollment: 20 (actual)

## Conditions studied

- Facioscapulohumeral Muscular Dystrophy

## Interventions

- **DRUG:** Testosterone Enanthate
- **DRUG:** Somatropin

## Key facts

- **NCT ID:** NCT03123913
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-18
- **Primary completion:** 2022-03-28
- **Final completion:** 2022-03-28
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03123913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03123913, "Study of Testosterone and rHGH in FSHD". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03123913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*